載入...
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
BACKGROUND: Multicolor flow cytometry (MFC) analysis is widely used to identify minimal residual disease (MRD) after treatment for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, current manual interpretation suffers from drawbacks of time consuming and interpreter idiosync...
Na minha lista:
| 發表在: | EBioMedicine |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6284584/ https://ncbi.nlm.nih.gov/pubmed/30361063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.10.042 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|